10-Q: Village Farms International Reports Q1 2025 Results: Cannabis Sales Dip, Produce Segment Faces Challenges

Sentiment:

Quarterly Report


Village Farms International's Q1 2025 results reveal a slight decrease in overall sales due to lower cannabis revenue, offset by growth in the produce segment, alongside a net loss attributable to shareholders.

Worse than expectedThe company's net loss increased compared to the same period last year.Adjusted EBITDA significantly decreased year-over-year.The company experienced a decrease in overall sales.

Summary

  • Village Farms International reported sales of $77.074 million for the three months ended March 31, 2025, a 1% decrease compared to $78.077 million in the same period of 2024.
  • The decrease was primarily due to lower Canadian Cannabis sales, which were impacted by unfavorable exchange rates, and a decrease in U.S. Cannabis sales.
  • VF Fresh (Produce) sales increased by $1.327 million, offsetting some of the cannabis revenue decline.
  • The company reported a net loss attributable to Village Farms International, Inc. shareholders of ($6.703) million, compared to a net loss of ($2.852) million for the same period in 2024.
  • Adjusted EBITDA for Q1 2025 was $81, a significant decrease from $3.591 million in Q1 2024.
  • The Canadian Cannabis segment saw a decrease in sales but an increase in gross profit and adjusted EBITDA.
  • The U.S. Cannabis segment experienced a decrease in sales but improved net income due to cost efficiencies.
  • The Produce segment faced challenges with increased cost of sales and a gross loss.
  • The company is taking steps to privatize certain assets and operations of its Fresh Produce segment.
  • Village Farms has until October 13, 2025, to regain compliance with Nasdaq's minimum bid price requirement.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there are positive aspects such as growth in international cannabis sales and strategic moves like the produce privatization, the overall financial performance is weaker than the previous year, with increased net losses and decreased adjusted EBITDA. The company also faces challenges in regaining compliance with Nasdaq listing requirements.

Positives

  • Canadian Cannabis segment saw an increase in gross profit and adjusted EBITDA.
  • Canadian Cannabis international sales increased 285% year-over-year.
  • U.S. Cannabis segment improved net income due to cost efficiencies.
  • The company expects international medical export sales to triple in fiscal year 2025, compared to fiscal year 2024.
  • Refinanced Pure Sunfarms Term Loans, consolidating three previous loans into one credit facility with improved terms.
  • Village Farms will receive $40 million in cash proceeds and a 37.9% equity ownership interest in Vanguard Food LP upon closing of the produce privatization transaction.

Negatives

  • Overall sales decreased by 1% to $77.074 million in Q1 2025 compared to Q1 2024.
  • Net loss attributable to Village Farms International, Inc. shareholders was ($6.703) million.
  • Adjusted EBITDA significantly decreased to $81 from $3.591 million year-over-year.
  • Canadian Cannabis sales decreased due to unfavorable exchange rates and a planned shift away from value-based product offerings.
  • U.S. Cannabis sales decreased due to new restrictions on CBD sales in additional states and lower direct-to-consumer sales.
  • VF Fresh (Produce) reported a gross loss of ($4.282) million due to increased cost of sales and lower margins on supply partner volumes.

Risks

  • The company's potential inability to regain compliance with the Nasdaq Stock Market's listing rules.
  • The company may fail to realize the expected benefits of privatizing certain assets and operations of its Fresh Produce segment.
  • The company is subject to restrictive covenants under its credit facilities.
  • The company faces risks related to the legal status of cannabis and cannabinoids in the United States.
  • The company is vulnerable to rising energy costs and inflationary effects on costs of cultivation and transportation.
  • The company faces recessionary effects on demand of its products.

Future Outlook

The company expects international medical export sales to triple in fiscal year 2025, as compared to fiscal year 2024.

Management Comments

  • The Companys vision is to be recognized as an international leader in consumer products developed from plants, whereby we produce and market value-added products that are consistently preferred by consumers.
  • Our focus for our Canadian Cannabis segment is to produce high quality cannabis, leveraging our low-cost production to provide preferred products at an attractive price that address the preferred consumer segments in the market.

Industry Context

The announcement reflects the ongoing challenges and shifts within the cannabis industry, including pricing pressures, regulatory changes, and the need for strategic adaptation. The company's diversification into produce and international markets is a common strategy to mitigate risks associated with the evolving cannabis landscape.

Comparison to Industry Standards

  • Canopy Growth, Tilray, and Aurora Cannabis are examples of Canadian cannabis companies that have faced similar challenges in terms of profitability and market share.
  • The company's focus on low-cost production aligns with industry trends as companies seek to improve margins and compete effectively.
  • The company's international expansion strategy mirrors that of other major cannabis players looking to capitalize on emerging markets.
  • The privatization of the produce segment is a strategic move to streamline operations and focus on core competencies, similar to actions taken by other companies in response to market pressures.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive Vice President and Global Chief Human Resources OfficerNAYvonne TrupianoNANew appointment

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Financial CovenantsThe company amended its loan with Farm Credit Canada (FCC Loan) to replace the fixed charge ratio covenant with a more favorable liquidity coverage ratio covenant.April 10, 2025This amendment was a result of the Companys considerable expansion and growth of Village Farms business since entering into the original credit agreement in 2013, as well a recognition of the Companys stronger strategic focus on its growing cannabis business.

Legal Proceedings

  • From time to time the Company is engaged in legal proceedings in the ordinary course of business.
  • We do not believe any current legal proceedings are material to our business.

Related Party Transactions

  • The Company leases its Rose office building from a Company employee who also owns a minority interest in Rose.
  • One of the Companys employees is related to a member of the Companys executive management team and received approximately $ 36 in salary and benefits during the three months ended March 31, 2025 and $ 30 in salary and benefits during the three months ended March 31, 2024 .

Stakeholder Impact

  • Shareholders: The net loss and potential delisting from Nasdaq may negatively impact shareholder value.
  • Employees: The privatization of the produce segment may lead to changes in employment for some employees.
  • Customers: The company's focus on high-quality products and international expansion may benefit customers through increased product availability and quality.
  • Suppliers: The privatization of the produce segment may impact relationships with suppliers in that sector.
  • Creditors: The refinancing of Pure Sunfarms Term Loans and the amendment of the FCC Loan may impact creditors.

Next Steps

  • Complete the privatization of certain assets and operations of its Fresh Produce segment.
  • Continue to focus on growing international cannabis business.
  • Regain compliance with Nasdaq's minimum bid price requirement by October 13, 2025.
  • Complete Phase II indoor cultivation facility in the town of Groningen expected to be complete in Q1 2026.

Key Dates

DateDescription
March 28, 2013Date of the original credit agreement issued by FCC to Village Farms Canada Limited Partnership.
September 6, 2024Start date of the 30-day period where the company's share price was below US$1.00, leading to a Nasdaq non-compliance notification.
October 17, 2024Date the company received notification from Nasdaq regarding non-compliance with the minimum bid price requirement.
October 18, 2024Date of the Nasdaq notification regarding non-compliance with the minimum bid price requirement.
December 31, 2024Date of the company's audited financial statements used for comparison.
March 31, 2025End date of the quarterly period for this report.
April 10, 2025Date the company entered into an Amended and Restated Credit Agreement with Farm Credit Canada.
April 16, 2025Initial deadline for Village Farms to regain compliance with Nasdaq's minimum bid price requirement.
April 17, 2025Date the company entered into a secured credit facility with a Canadian chartered bank.
April 21, 2025Date Nasdaq approved the company's request for a 180-day extension to regain compliance with the minimum bid price requirement.
May 5, 2025Date as of which 112,337,049 common shares of the registrant were outstanding.
May 12, 2025Date of the report.
October 13, 2025New deadline for Village Farms to regain compliance with Nasdaq's minimum bid price requirement.

Keywords

Village Farms International, cannabis, produce, financial results, Q1 2025, EBITDA, sales, net loss, Pure Sunfarms, Balanced Health, Leli Holland, VF Fresh

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.